Laurus Labs P/B Ratio

Current P/B Ratio
13.83
High Valuation
Very High - Significant premium, high growth expectations or speculative

Laurus Labs (LAURUSLABS) P/B ratio is 13.83 (High), book value per share ₹490.74 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Compare with LAURUSLABS fair price to assess whether the stock is under or overvalued.

Current Valuation Metrics

P/B Ratio 13.83
Current Price ₹1381.70
Book Value/Share ₹490.74
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹5,300 Cr
Share Capital ₹108 Cr
Reserves & Surplus ₹5,192 Cr
Outstanding Shares 108,000,000
Book Value per Share ₹490.74

Valuation Signal

Signal Overvalued
Historical Avg 1.87
Historical Range 1.15 - 2.82
Percentile 100.0%

Sector Context

Sector Average -0.33
Sector Median 0.63
Sector Rank #11 of 50
Sector Percentile 22.0%

LAURUSLABS P/B Ratio — Valuation Insights & Book Value Analysis

Laurus Labs price-to-book ratio interpretation, valuation status and historical context — current P/B 13.83 (High). For live price, earnings yield and the full fundamental profile, see LAURUSLABS screener.

  • Stock appears overvalued with PB of 13.83, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 638.8% above historical average
  • Trading at premium to sector average PB of -0.33

Laurus Labs P/B Ratio Historical Trend

LAURUSLABS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View LAURUSLABS annual price range for the annual high/low range and current price position.

LAURUSLABS Historical P/B Ratio — Book Value Per Share & Year-End Price

Laurus Labs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 2.82 ₹490.74 ₹1381.70 ₹5,300 Moderate
2025 2.6 ₹426.2 ₹1108.00 ₹4,603 Moderate
2024 1.58 ₹381.11 ₹602.70 ₹4,116 Moderate
2023 1.15 ₹374.91 ₹430.20 ₹4,049 Moderate
2022 1.21 ₹311.02 ₹375.25 ₹3,359 Moderate

LAURUSLABS vs Healthcare Peers — P/B Ratio Comparison

Laurus Labs P/B 13.83 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.

Sector Average
-0.33
Sector Median
0.63
Lowest P/B
-17.92
Highest P/B
1.01
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.92 ₹22 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Parmax Pharma PARMAX -2.48 ₹14 Low
Bharat Immunologicals BIBCL -2.32 ₹76 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹127 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.63 ₹53 Low